Advertisement

Ads Placeholder
Loading...

Global Cord Blood Corporation

CORBF•PNK
Healthcare
Medical - Diagnostics & Research
$1.05
$0.05(5.000%)
U.S. Market opens in 58h 2m

Global Cord Blood Corporation (CORBF) Stock Overview

Explore Global Cord Blood Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap140.6M
P/E Ratio1.75
EPS (TTM)$0.35
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$0.89
3 Months$0.57
1 Year Target$0.65

CORBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Global Cord Blood Corporation (CORBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1.75 and a market capitalization of 140.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.00%
5-Day Change
5.00%
1-Month Change
10.53%
3-Month Change
10.53%
6-Month Change
5.00%
Year-to-Date (YTD) Change
10.53%
1-Year Change
N/A
3-Year Change
-64.88%
5-Year Change
-77.17%
All-Time (Max) Change
-80.91%

Contact Information

https://www.globalcordbloodcorp.com
852 3605 8180
Bank of China Tower, Central, NaN, NaN

Company Facts

12,020 Employees
IPO DateMay 9, 2007
CountryHK
Actively Trading

Frequently Asked Questions